CROSSTALK THERAPEUTICS LTD
Company number 13162770 · Monitor this company
Executive summary
Crosstalk Therapeutics Ltd operates as an early-stage, venture-backed biotech R&D company in the UK, typical of firms in this innovation-intensive sector with negative net assets and reliance on investor funding. Its positioning as a niche player is reinforced by specialized VC involvement and prudent cash management, but it faces common sector challenges including funding dependency and long development timelines. The company’s financial profile aligns with industry norms for small, research-focused biotech entities progressing toward commercial viability.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-01-27
- Registered office
- Innovation House Innovation Way, Discovery Park, Sandwich, Kent, United Kingdom, CT13 9FF
- Postcode
- CT13 9FF
- Capital
- 69 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-01-28
- Next due by
- 2027-02-11
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 2 resigned
Michael, President GLADSTONE
Director
Jernej, Dr GODEC
Director
MR Nicholas Alexander WILLIAMS
Director